Publication: Unraveling CD69 signaling pathways, ligands and laterally associated molecules.
Loading...
Identifiers
Publication date
Advisors
Journal Title
Journal ISSN
Volume Title
Publishers
Leibniz Research Centre for Working Environment and Human Factors
Abstract
CD69 is an early leukocyte activation marker involved in the regulation of the immune response. Initial studies evaluated its function using monoclonal antibodies until knock-out mice were developed. Subsequently, four ligands for CD69 have been identified, namely galectin-1, S100A8/S100A9 complex, myosin light chains 9 and 12, and oxidized low-density lipoproteins. In addition, several molecules are laterally associated with and regulated by CD69, including calreticulin and two transmembrane receptors, sphingosine-1-phosphate receptor (S1P1) and the heterodimeric amino acid transporter complex SLC7A5-SLC3A2 (LAT1-CD98). Recently, CD69 engagement has been shown to induce the expression of the immunoregulatory receptor programmed cell death-1 (PD-1) in T cells. The molecular signaling induced by CD69 has been explored in different scenarios and cell types. This review provides a perspective on the molecular pathways, ligands and cellular functions known to be regulated by CD69.
Description
This work was supported by grant P2022/BMD7209-INTEGRAMUNE from the Comunidad de Madrid to FS-M and PM, a grant from “La Caixa” Banking Foundation (HR17-00016) to FS-M; the Spanish Ministerio de Ciencia e Innovación (PDC2021-121719-I00 and PID-2020-120412RB-I00 to FS-M); and grants from the Instituto de Salud Carlos III (PI21/01583 to HF; PI22/01842 to DC; and PI22/01759 to PM). M. Jiménez-Fernández is supported by Formación de Personal Investigador Severo Ochoa (FPI-SO) Program (PRE2019-087941). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), the Ministerio de Ciencia e Innovación and the Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV2015-0505).
MeSH Terms
DeCS Terms
Bibliographic citation
EXCLI J. 2023 Mar 16:22:334-351.





